M. Hariharan

In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18.

R. Bhardwaj, S. Shenoy, J. Iravane, 2019, The Journal of antimicrobial chemotherapy.